NCT00444509View on ClinicalTrials.gov

Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 17, 2007

Primary Completion Date

April 9, 2007

Study Completion Date

April 9, 2007

Conditions
Asthma
Interventions
DRUG

GW685698X

GW685698X will available with a unit dose strength of 400 mcg that will be inhaled via DISKUS

DRUG

GW685698X containing magnesium stearate

GW685698X containing magnesium stearate will available with a unit dose strength of 400 mcg that will be inhaled via DISKUS

Trial Locations (1)

6035

GSK Investigational Site, Wellington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY